JP2023549851A5 - - Google Patents
Info
- Publication number
- JP2023549851A5 JP2023549851A5 JP2023528641A JP2023528641A JP2023549851A5 JP 2023549851 A5 JP2023549851 A5 JP 2023549851A5 JP 2023528641 A JP2023528641 A JP 2023528641A JP 2023528641 A JP2023528641 A JP 2023528641A JP 2023549851 A5 JP2023549851 A5 JP 2023549851A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- cdr1
- cdr2
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063115436P | 2020-11-18 | 2020-11-18 | |
| US63/115,436 | 2020-11-18 | ||
| PCT/US2021/059701 WO2022109010A1 (en) | 2020-11-18 | 2021-11-17 | Heavy chain antibodies binding to folate receptor alpha |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549851A JP2023549851A (ja) | 2023-11-29 |
| JP2023549851A5 true JP2023549851A5 (https=) | 2024-11-25 |
Family
ID=79024440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528641A Pending JP2023549851A (ja) | 2020-11-18 | 2021-11-17 | 葉酸受容体アルファに結合する重鎖抗体 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20240002498A1 (https=) |
| EP (1) | EP4247498A1 (https=) |
| JP (1) | JP2023549851A (https=) |
| KR (1) | KR20230110303A (https=) |
| CN (1) | CN116615253A (https=) |
| AR (1) | AR124084A1 (https=) |
| AU (1) | AU2021383743A1 (https=) |
| CA (1) | CA3199785A1 (https=) |
| CL (2) | CL2023001432A1 (https=) |
| CO (1) | CO2023006790A2 (https=) |
| CR (1) | CR20230259A (https=) |
| IL (1) | IL302670A (https=) |
| JO (1) | JOP20230109A1 (https=) |
| MX (1) | MX2023005693A (https=) |
| PE (1) | PE20231203A1 (https=) |
| TW (1) | TW202233684A (https=) |
| UY (1) | UY39522A (https=) |
| WO (1) | WO2022109010A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL322083A (en) | 2016-08-24 | 2025-09-01 | Teneobio Inc | Non-human transgenic animals that produce modified heavy chain antibodies only |
| IL317134A (en) | 2016-12-21 | 2025-01-01 | Teneobio Inc | An antibody containing only heavy chains that binds a human B-cell maturation antigen, a pharmaceutical composition containing the same, its use in the treatment of B-cell disorders and a method for its preparation |
| CN111683966B (zh) | 2017-12-22 | 2023-07-11 | 特尼奥生物股份有限公司 | 与cd22结合的重链抗体 |
| WO2020206330A1 (en) | 2019-04-05 | 2020-10-08 | Teneobio, Inc. | Heavy chain antibodies binding to psma |
| CR20210622A (es) | 2019-06-14 | 2022-06-27 | Teneobio Inc | Anticuerpos multiespecíficos de cadena pesada que se unen a cd22 y cd3 |
| WO2025252094A1 (zh) * | 2024-06-05 | 2025-12-11 | 长春金赛药业有限责任公司 | 靶向叶酸受体α(FRα)的抗体、双特异性抗体和偶联物，及其制备和用途 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| GB0115256D0 (en) | 2001-06-21 | 2001-08-15 | Babraham Inst | Mouse light chain locus |
| AU2003217912A1 (en) * | 2002-03-01 | 2003-09-16 | Xencor | Antibody optimization |
| WO2004042017A2 (en) | 2002-10-31 | 2004-05-21 | Genentech, Inc. | Methods and compositions for increasing antibody production |
| EP1585768A2 (en) | 2003-01-23 | 2005-10-19 | Genentech, Inc. | Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture |
| KR101151957B1 (ko) | 2004-07-22 | 2012-06-01 | 로저 킹돈 크레이그 | 결합 분자 |
| US20160355591A1 (en) | 2011-05-02 | 2016-12-08 | Immunomedics, Inc. | Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies |
| US20100122358A1 (en) | 2008-06-06 | 2010-05-13 | Crescendo Biologics Limited | H-Chain-only antibodies |
| MX341884B (es) | 2009-03-10 | 2016-09-07 | Biogen Ma Inc | Anticuerpos anti-antigeno de maduracion de celulas b (bcma). |
| GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| US9345661B2 (en) | 2009-07-31 | 2016-05-24 | Genentech, Inc. | Subcutaneous anti-HER2 antibody formulations and uses thereof |
| US20140308285A1 (en) * | 2013-03-15 | 2014-10-16 | Amgen Inc. | Heterodimeric bispecific antibodies |
| US20140302037A1 (en) * | 2013-03-15 | 2014-10-09 | Amgen Inc. | BISPECIFIC-Fc MOLECULES |
| PT3221356T (pt) * | 2014-11-20 | 2020-10-29 | Hoffmann La Roche | Moléculas de ligação ao antigénio biespecíficas ativadoras das células t contra folr1 e cd3 |
| EP4141032B1 (en) * | 2014-11-20 | 2024-05-29 | F. Hoffmann-La Roche AG | Combination therapy of t cell activating bispecific antigen binding molecules and pd-1 axis binding antagonists |
| KR20250175345A (ko) | 2016-06-21 | 2025-12-16 | 테네오바이오, 인코포레이티드 | Cd3 결합 항체 |
| IL322083A (en) | 2016-08-24 | 2025-09-01 | Teneobio Inc | Non-human transgenic animals that produce modified heavy chain antibodies only |
| PE20241349A1 (es) | 2016-09-14 | 2024-07-03 | Teneobio Inc | Anticuerpos de union a cd3 |
| AU2019236091B2 (en) * | 2018-03-13 | 2025-06-05 | Phanes Therapeutics, Inc. | Anti-folate receptor 1 antibodies and uses thereof |
| WO2020206330A1 (en) * | 2019-04-05 | 2020-10-08 | Teneobio, Inc. | Heavy chain antibodies binding to psma |
-
2021
- 2021-11-11 TW TW110142033A patent/TW202233684A/zh unknown
- 2021-11-17 WO PCT/US2021/059701 patent/WO2022109010A1/en not_active Ceased
- 2021-11-17 CN CN202180077625.6A patent/CN116615253A/zh active Pending
- 2021-11-17 US US18/253,197 patent/US20240002498A1/en active Pending
- 2021-11-17 PE PE2023001680A patent/PE20231203A1/es unknown
- 2021-11-17 CR CR20230259A patent/CR20230259A/es unknown
- 2021-11-17 JP JP2023528641A patent/JP2023549851A/ja active Pending
- 2021-11-17 AU AU2021383743A patent/AU2021383743A1/en active Pending
- 2021-11-17 CA CA3199785A patent/CA3199785A1/en active Pending
- 2021-11-17 KR KR1020237020120A patent/KR20230110303A/ko active Pending
- 2021-11-17 IL IL302670A patent/IL302670A/en unknown
- 2021-11-17 MX MX2023005693A patent/MX2023005693A/es unknown
- 2021-11-17 EP EP21824720.3A patent/EP4247498A1/en active Pending
- 2021-11-17 AR ARP210103178A patent/AR124084A1/es unknown
- 2021-11-18 UY UY0001039522A patent/UY39522A/es unknown
-
2023
- 2023-05-18 JO JOJO/P/2023/0109A patent/JOP20230109A1/ar unknown
- 2023-05-18 CL CL2023001432A patent/CL2023001432A1/es unknown
- 2023-05-25 CO CONC2023/0006790A patent/CO2023006790A2/es unknown
-
2025
- 2025-10-14 CL CL2025003126A patent/CL2025003126A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023549851A5 (https=) | ||
| JP2022061992A5 (https=) | ||
| TWI821474B (zh) | Ｃｄ３抗體及其藥物用途 | |
| JP6719477B2 (ja) | 抗ｔｉｍ−３抗体 | |
| JP2023509448A5 (https=) | ||
| JP2019536430A5 (https=) | ||
| JP2021534762A5 (https=) | ||
| RU2019128134A (ru) | Антитело против gprc5d и молекула, содержащая антитело | |
| JP2019501883A5 (https=) | ||
| JP7460551B2 (ja) | 抗ｈｅｒ２抗体 | |
| JP2023538945A5 (https=) | ||
| JP2019532625A5 (https=) | ||
| WO2018137576A1 (zh) | 抗pd-1单克隆抗体及其制备方法和应用 | |
| JP2022504802A5 (https=) | ||
| JP2021510521A5 (https=) | ||
| JP2018527919A5 (https=) | ||
| JP2023551027A5 (https=) | ||
| JP2010535012A5 (https=) | ||
| JP2021511811A5 (https=) | ||
| JP2012501670A5 (https=) | ||
| JP2023526774A5 (https=) | ||
| JP2022551836A (ja) | Ｂｃｍａを標的とする抗体、二重特異性抗体及びその用途 | |
| JP2022521705A5 (https=) | ||
| JP2018505681A5 (https=) | ||
| JP2023511898A5 (https=) |